Daniel Lin

2.8k total citations
50 papers, 1.0k citations indexed

About

Daniel Lin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Daniel Lin has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 9 papers in Surgery. Recurrent topics in Daniel Lin's work include Prostate Cancer Treatment and Research (11 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Daniel Lin is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Daniel Lin collaborates with scholars based in United States, Taiwan and Netherlands. Daniel Lin's co-authors include Cullen M. Taniguchi, Yanqing Huang, Jonathan L. Wright, Michael P. Porter, Paul H. Lange, Christopher I. Li, Jeannette M. Schenk, Kathryn B. Arnold, Marian L. Neuhouser and Guido Dalbagni and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Daniel Lin

46 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Lin United States 16 327 290 261 235 220 50 1.0k
Howard L. Adler United States 17 432 1.3× 235 0.8× 211 0.8× 437 1.9× 348 1.6× 37 1.2k
Kristen Lecksell United States 17 185 0.6× 95 0.3× 307 1.2× 306 1.3× 338 1.5× 22 964
Zhenjie Wu China 21 742 2.3× 501 1.7× 213 0.8× 276 1.2× 439 2.0× 59 1.4k
P Lipponen Finland 18 592 1.8× 293 1.0× 133 0.5× 407 1.7× 229 1.0× 35 1.4k
Paul M. Spring United States 17 286 0.9× 195 0.7× 215 0.8× 260 1.1× 172 0.8× 35 1.0k
Anna Maria Aglianò Italy 22 486 1.5× 330 1.1× 250 1.0× 654 2.8× 185 0.8× 43 1.3k
H. Heynemann Germany 15 261 0.8× 209 0.7× 226 0.9× 316 1.3× 385 1.8× 48 825
Salomé González‐Reyes Spain 17 252 0.8× 334 1.2× 170 0.7× 322 1.4× 157 0.7× 34 974
Di Song China 15 224 0.7× 91 0.3× 136 0.5× 160 0.7× 136 0.6× 61 807
Trudy Jonges Netherlands 11 245 0.7× 171 0.6× 279 1.1× 229 1.0× 104 0.5× 19 826

Countries citing papers authored by Daniel Lin

Since Specialization
Citations

This map shows the geographic impact of Daniel Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lin more than expected).

Fields of papers citing papers by Daniel Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lin. The network helps show where Daniel Lin may publish in the future.

Co-authorship network of co-authors of Daniel Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Lin. A scholar is included among the top collaborators of Daniel Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Lin. Daniel Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bloom, Matthew B., et al.. (2025). Advances in Immunotherapy in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 26(5). 1936–1936. 5 indexed citations
2.
Lin, Yi‐Chen, Shih‐Hung Yang, Daniel Lin, et al.. (2025). Antitumor efficacy achieved by targeting PEGylated nanomedicines to netrin-1 in the extracellular matrix or EphA2 on the cancer cell membrane. Journal of Controlled Release. 385. 114042–114042.
3.
Anné, Pramila R., Karen Mooney, Maria Werner‐Wasik, et al.. (2024). Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma. Radiation Oncology. 19(1). 65–65. 1 indexed citations
4.
Newcomb, Lisa F., Jeannette M. Schenk, Yingye Zheng, et al.. (2024). Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer. JAMA. 331(24). 2084–2084. 22 indexed citations
5.
6.
Zeng, Jing, Jiajun Chen, Emily S. Weg, et al.. (2023). Proton Radiation Therapy for Stage IIA/IIB Testicular Seminoma. International Journal of Radiation Oncology*Biology*Physics. 117(2). e411–e412. 1 indexed citations
7.
Lee, Jaewon J., Vincent Bernard, Alexander Semaan, et al.. (2021). Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies. Clinical Cancer Research. 27(21). 5912–5921. 68 indexed citations
8.
Fuentes, Natividad R., et al.. (2020). Resolving the HIF paradox in pancreatic cancer. Cancer Letters. 489. 50–55. 10 indexed citations
9.
Lin, Daniel, Ramez Kouzy, Joseph Abi Jaoude, et al.. (2020). Microbiome factors in HPV-driven carcinogenesis and cancers. PLoS Pathogens. 16(6). e1008524–e1008524. 48 indexed citations
10.
Jaoude, Joseph Abi, Ramez Kouzy, Nicholas D. Nguyen, et al.. (2020). Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies. Current Problems in Cancer. 44(6). 100607–100607. 16 indexed citations
11.
Moningi, Shalini, Joseph Abi Jaoude, Ramez Kouzy, et al.. (2020). Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer. Advances in Radiation Oncology. 6(2). 100621–100621. 10 indexed citations
12.
Fujimoto, Tara N., Lauren E. Colbert, Yanqing Huang, et al.. (2019). Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. Cancer Research. 79(9). 2327–2338. 22 indexed citations
13.
Yu, Meifang, Nicholas D. Nguyen, Yanqing Huang, et al.. (2019). Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. JCI Insight. 4(16). 129 indexed citations
14.
Molkentine, Jessica M., Tara N. Fujimoto, Thomas D. Horvath, et al.. (2019). Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated Radiation. Scientific Reports. 9(1). 1949–1949. 15 indexed citations
15.
Huang, Yanqing, Daniel Lin, & Cullen M. Taniguchi. (2017). Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?. Science China Life Sciences. 60(10). 1114–1124. 108 indexed citations
16.
Wang, Xia, et al.. (2016). Influence of raltegravir intensification on viral load and 2-LTR dynamics in HIV patients on suppressive antiretroviral therapy. Journal of Theoretical Biology. 416. 16–27. 26 indexed citations
17.
Lin, Daniel. (2015). Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target. World Journal of Gastroenterology. 21(42). 12171–12171. 100 indexed citations
18.
Schenk, Jeannette M., Alan R. Kristal, Kathryn B. Arnold, et al.. (2011). Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer: Results from the Prostate Cancer Prevention Trial. American Journal of Epidemiology. 173(12). 1419–1428. 46 indexed citations
19.
Wright, Jonathan L., Michael P. Porter, Christopher I. Li, Paul H. Lange, & Daniel Lin. (2006). Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer. 107(4). 721–728. 136 indexed citations
20.
Lin, Daniel, David Thorning, & John N. Krieger. (1999). Primary penile lymphoma: diagnostic difficulties and management options. Urology. 54(2). 366–366. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Howard L. Adler Breakdown of academic impact, for papers by Kristen Lecksell Breakdown of academic impact, for papers by Zhenjie Wu Breakdown of academic impact, for papers by P Lipponen Breakdown of academic impact, for papers by Paul M. Spring Breakdown of academic impact, for papers by Anna Maria Aglianò Breakdown of academic impact, for papers by H. Heynemann Breakdown of academic impact, for papers by Salomé González‐Reyes Breakdown of academic impact, for papers by Di Song Breakdown of academic impact, for papers by Trudy Jonges
Rankless by CCL
2026